A24 Drops a Three-Year Secret Documentary on Elizabeth Holmes at Telluride
Usagevpn.com – In an industry where every new release is buried under months of trailers, social-media campaigns, and advance screenings, a truly unannounced premiere remains almost unheard of. Yet that is precisely what A24 accomplished when it slipped a feature-length documentary into a closed screening at the Telluride Film Festival. The film, titled You Can See Everything, had been in production since 2023 under conditions of near-total confidentiality, and its existence was effectively unknown to the public until the moment it hit the big screen.
What the Film Tracks
The documentary centers on Elizabeth Holmes, the former chief executive of Theranos, the health-technology startup whose collapse became one of the most scrutinized corporate scandals of the early 2020s. Holmes was found guilty of defrauding investors and received a prison sentence exceeding eleven years in 2022. She reported to federal custody in May 2023.
According to the film’s official synopsis, Holmes personally invited the two directors into her home to record thirty-four days of her life in the period immediately preceding her incarceration. Rather than stopping at that window, the filmmakers continued to shadow Holmes for the full span of three years, producing what the synopsis describes as:
“What begins as an intimate portrait of an enigmatic felon becomes a mind-bending three-year journey into the abyss.”
Behind the Camera
The project is a co-direction effort between Canadian comedian and writer Nathan Fielder and filmmaker Lance Oppenheim. For Fielder, it represents his first feature-length directorial credit. For Oppenheim, it is his second directorial work to premiere within a matter of days, following the Venice Film Festival debut of Primetime, a Robert Pattinson-led feature.
Vanity Fair confirmed that Fielder did not merely visit Holmes during production; he lived in her household alongside her husband, Billy Evans, for the duration of the shoot. The publication characterized the finished film as being “full of unexpected twists and turns and shocking reveals,” a description that suggests the narrative arc departs considerably from a straightforward prison-visit format.
The Trailer’s Unsettling Tone
On the same day as the Telluride screening, A24 published both a teaser trailer and a promotional poster. The trailer adopts an almost horror-adjacent register. The lens locks onto Holmes’s face, capturing what the synopsis calls her signature wide-eyed stare, as she insists she is not deceiving anyone in the room.
“Why would I do that?”
A skeptical Fielder, visible on camera, pushes back:
“You’re being real right now?”
“I’m always being real,” Holmes replies.
The shot then pulls back to reveal that Holmes has been gently rocking a young infant throughout the exchange — a detail that reframes the preceding dialogue and injects an immediate layer of unease into what might otherwise read as a simple interview moment.
The Theranos Backstory
For readers who may have followed the saga only in fragments, the Holmes story is a textbook case of how capital markets can reward narrative over evidence. Holmes reportedly left Stanford University at nineteen to build a company promising a blood-testing technology that required only a few drops from a finger. As CEO, she assembled a board of former U.S. senators and two ex-secretaries of state, lending the venture an aura of institutional legitimacy.
In 2015, Forbes named her the youngest and wealthiest self-made female billionaire in the United States, anchoring that distinction to a nine-billion-dollar company valuation. Holmes had raised roughly $945 million from investors that included media magnate Rupert Murdoch and tech entrepreneur Larry Ellison. The company’s flagship diagnostic method, however, was ultimately shown never to have functioned as advertised. Holmes was convicted of fraud and sentenced to eleven years and three months.
The arc from Stanford dropout to billionaire to federal inmate has since been mined extensively across media formats. Alex Gibney directed the HBO documentary The Inventor: Out for Blood in Silicon Valley, and the Apple TV+ miniseries The Dropout cast Amanda Seyfried as Holmes, a performance that earned her an Emmy. Podcasts, investigative books, and countless op-eds have treated the Theranos collapse as a Silicon Valley cautionary tale about the dangers of charismatic leadership untethered from technical reality.
Post-Conviction and What Comes Next
Following her conviction, Holmes attempted to leave the United States and has continued to press for a new trial. Her scheduled release date from federal prison is 16 August 2032.
You Can See Everything is slated for U.S. theatrical release next month, though A24 has not yet pinned down a specific date. No European release window has been announced as of this writing.
The film’s arrival raises questions that extend beyond celebrity gossip. When a convicted fraudster grants a filmmaker three years of unrestricted access — including cohabitation — the resulting portrait inevitably blurs the line between documentary and collaboration. Holmes, by inviting Fielder and Oppenheim into her most vulnerable period, gained a narrative platform that few other defendants have enjoyed. Whether that platform ultimately rehabilitates, complicates, or further entangles her public image will depend on how the audience receives the finished cut. What is clear from the available material is that A24 intended the experience to be disorienting, and the trailer suggests the studio succeeded in making viewers feel, briefly, that they are watching something they cannot quite trust.
Related Reading
Frequently Asked Questions
What is You Can See Everything?
You Can See Everything is the main topic of this guide. The article explains the context, practical details, and next steps readers should understand.
Why does You Can See Everything matter?
You Can See Everything matters because readers are looking for a useful answer, not just a short summary. Good content should match search intent and help them decide what to do next.

